<HTML>
<HEAD>
<LINK REL="stylesheet" TYPE="text/css" HREF="/public/css/efacts_stylesheet_all.css">
<LINK REL="stylesheet" TYPE="text/css" HREF="/public/css/efacts_stylesheet_other.css">
<!-- user agent: Python-urllib/2.7 -->
<TITLE>About</TITLE>
</HEAD>
<BODY>
<SCRIPT LANGUAGE="JavaScript" TYPE="text/javascript"><!--
	var ssl_prefix = '';
	var ol_hauto = 1;
	var ol_vauto = 1;
	var ol_fgclass = 'ss_ol_fg';
	var ol_bgclass = 'ss_ol_bg';
	var ol_textfontclass = 'ss_ol_main';
	var ol_captionfontclass = 'ss_ol_caption';
	var syscolor_0 = '#000000';
	var syscolor_1 = '#001e5b';
	var syscolor_2 = '#faffac';
	var syscolor_3 = '#eeeeee';
	var syscolor_4 = '#bfb75b';
	var syscolor_5 = '#eef3f7';
	var syscolor_6 = '#ffffff';
	var syscolor_7 = '#ffffff';
	var syscolor_8 = '#FFC71D';
	var syscolor_9 = '#000000';
	var syscolor_10 = '#000000';
	var syscolor_11 = '#000000';
	var b_ns4 = (navigator.appName == 'Netscape' && parseInt(navigator.appVersion) == 4);
	var b_ns6 = (document.getElementById) ? true : false;
	var b_msie = (document.all) ? true : false;
	var b_ie4 = false;
	var b_ie5 = false;
	var b_ie6 = false;
	var b_gecko = (navigator.userAgent.indexOf('Gecko') != -1 && navigator.userAgent.indexOf('Safari') == -1);
	var gecko_version = (b_gecko ? navigator.userAgent.substr(navigator.userAgent.lastIndexOf('Gecko/')+6, 8) : -1);
	var b_quirks = false;
	
	if(b_msie) {
		if(b_ns6)
			b_ns6 = false;
		if(navigator.userAgent.indexOf('MSIE 6') > 0)
			b_ie6 = true;
		else if(navigator.userAgent.indexOf('MSIE 5') > 0)
			b_ie5 = true;
		else
			b_ie4 = true;
	}
	
	if(b_msie || b_ns6) 
		b_quirks = (document.compatMode=='BackCompat') ? true : false;
// -->
</SCRIPT>
<!-- overlays done using overLIB (c) Erik Bosrup -->
<DIV ID="overDiv" STYLE="position:absolute; visibility:hidden; z-index:1000;"></DIV>
<SCRIPT LANGUAGE="JavaScript" SRC="/public/scripts/overlib/mini/overlib_mini.js" TYPE="text/javascript"></SCRIPT>
<SCRIPT LANGUAGE="JavaScript" SRC="/public/scripts/overlib/mini/overlib_hideform_mini.js" TYPE="text/javascript"></SCRIPT>
<SCRIPT LANGUAGE="JavaScript" SRC="/public/scripts/scripts.js" TYPE="text/javascript"></SCRIPT>
<table class="rootTable" width="100%" cellpadding="0" cellspacing="0">
<tr>
<td>

<table class="rootHeader" cellpadding="0" cellspacing="0"> 
<tbody><tr> 
<td class="rootLogo"><IMG SRC="/html/final_efacts_logo.png?asgsid=937c19af8a660d335338ef84ffdb650c" BORDER="0" ALT="efacts_logo"></td> 
<td class="rootBanner"><IMG SRC="/html/seventh_framework.png?asgsid=937c19af8a660d335338ef84ffdb650c" BORDER="0"></td> 
<td class="rootTools"> &nbsp; <div class="rootMessenger"><DIV CLASS="img_hmenu"></DIV></div> <div class="rootUserName"><SPAN CLASS="ss_user_name"><A href="/html/studies/admin?asgsid=937c19af8a660d335338ef84ffdb650c">&nbsp;</A></SPAN></div><div class="rootSwitch"></div> <div class="rootLanguage"><SPAN CLASS="ss_langswitch_flat"><A HREF="?set-language-to=en&asgsid=937c19af8a660d335338ef84ffdb650c"><SPAN CLASS="ss_langswitch_flat_selected">English</SPAN></A> | <A HREF="?set-language-to=fr&asgsid=937c19af8a660d335338ef84ffdb650c">Français</A> | <A HREF="?set-language-to=de&asgsid=937c19af8a660d335338ef84ffdb650c">Deutsch</A> | <A HREF="?set-language-to=es&asgsid=937c19af8a660d335338ef84ffdb650c">Español</A> | <A HREF="?set-language-to=it&asgsid=937c19af8a660d335338ef84ffdb650c">Italiano</A> | <A HREF="?set-language-to=nl&asgsid=937c19af8a660d335338ef84ffdb650c">Nederlands</A></SPAN></div> </td>
</tr>
 </tbody>
 </table>
 <table class="rootMainNav" cellpadding="0" cellspacing="0">
 <tbody>
 <tr>
 <td class="rootNavPrepend">&nbsp;&nbsp;&nbsp;</td>
 <td><TABLE CLASS="ss_hmenu" BORDER="0" CELLSPACING="0" CELLPADDING="0">
<TR>
<TD CLASS="ss_hmenu_sel"><SPAN STYLE="white-space: nowrap; "><A HREF="/html/studies/home?clps3718_n1635066013=1&asgsid=937c19af8a660d335338ef84ffdb650c">About</A></SPAN></TD>
<TD CLASS="ss_hmenu_uns"><SPAN STYLE="white-space: nowrap; "><A HREF="/html/studies/project/disease?asgsid=937c19af8a660d335338ef84ffdb650c">Project</A></SPAN></TD>
<TD CLASS="ss_hmenu_uns"><SPAN STYLE="white-space: nowrap; "><A HREF="/html/studies/about/steering?asgsid=937c19af8a660d335338ef84ffdb650c">Network</A></SPAN></TD>
<TD CLASS="ss_hmenu_uns"><SPAN STYLE="white-space: nowrap; "><A HREF="/html/studies/links?asgsid=937c19af8a660d335338ef84ffdb650c">Links</A></SPAN></TD>
<TD CLASS="ss_hmenu_uns"><SPAN STYLE="white-space: nowrap; "><A HREF="/html/studies/contact?asgsid=937c19af8a660d335338ef84ffdb650c">Contact us</A></SPAN></TD>
</TR>
</TABLE>
</td>
 <td><TABLE CLASS="login_hmenu" BORDER="0" CELLSPACING="0" CELLPADDING="0">
<TR>
<TD CLASS="login_hmenu_uns"><SPAN STYLE="white-space: nowrap; "><A HREF="/html/login?asgsid=937c19af8a660d335338ef84ffdb650c">Login</A></SPAN></TD>
</TR>
</TABLE>
</td>
 <td class="rootNavAppend">&nbsp;</td>
 </tr>
 </tbody></table>
 <table class="rootLayout" cellpadding="0" cellspacing="0">
 <tbody><tr>
 <td colspan="2">&nbsp;</td>
 </tr>
 <tr>
 <td class="rootMenu"><DIV CLASS="ss_vmenu"><TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0 CLASS="ss_vmenu_tab" ID="id_3718_1">
<TR><TD NOWRAP CLASS="ss_vmenu_uns" COLSPAN="2"><IMG SRC="/public/px.gif?asgsid=937c19af8a660d335338ef84ffdb650c" WIDTH=11 HEIGHT=9 ALT="--->"><A HREF="/html/studies/home/news?asgsid=937c19af8a660d335338ef84ffdb650c" >News</A></TD>
</TR>
<TR><TD NOWRAP CLASS="ss_vmenu_uns" COLSPAN="2"><IMG SRC="/public/px.gif?asgsid=937c19af8a660d335338ef84ffdb650c" WIDTH=11 HEIGHT=9 ALT="--->"><A HREF="/html/studies/home/publications?asgsid=937c19af8a660d335338ef84ffdb650c" >Publications</A></TD>
</TR>
<TR><TD NOWRAP CLASS="ss_vmenu_uns" COLSPAN="2"><IMG SRC="/public/px.gif?asgsid=937c19af8a660d335338ef84ffdb650c" WIDTH=11 HEIGHT=9 ALT="--->"><A HREF="/html/studies/home/patients?asgsid=937c19af8a660d335338ef84ffdb650c" >For Patients</A></TD>
</TR>
<TR><TD NOWRAP CLASS="ss_vmenu_uns" COLSPAN="2"><A HREF="/html/studies/home/newsletter?asgsid=937c19af8a660d335338ef84ffdb650c" ><IMG SRC="/public/efacts_pfeil_rechts.gif?asgsid=937c19af8a660d335338ef84ffdb650c" ALT="[+]">Newsletter</A></TD>
</TR>
<TR><TD NOWRAP CLASS="ss_vmenu_uns" COLSPAN="2"><A HREF="/html/studies/home/studyloc?asgsid=937c19af8a660d335338ef84ffdb650c" ><IMG SRC="/public/efacts_pfeil_rechts.gif?asgsid=937c19af8a660d335338ef84ffdb650c" ALT="[+]">Study Locations</A></TD>
</TR>
</TABLE></DIV>
</td>
 <td class="rootRight">
 <table class="rootContentBox" cellpadding="0" cellspacing="0">
 <tbody>
 <tr>
 <td class="rootTitleBar">
 <table cellpadding="0" cellspacing="0" width="100%">
 <tbody><tr>
 <td class="rootTitle">About EFACTS</td>
 <td class="rootModeSwitch"><SPAN CLASS="ss_mode_switch"></SPAN></td>
 </tr>
 </tbody></table>
 </td>
 </tr>
 <tr>
 <td class="rootContent"><TABLE CLASS="ss_txt" CELLSPACING="0" CELLPADDING="0"><TR><TD VALIGN="top"><P CLASS="ss_par" STYLE="margin-bottom: 1ex; margin-top: 0ex;"><span style="font-weight: bold;">EFACTS</span> (<span style="font-style: italic;">the European Friedreich’s Ataxia Consortium for Translational Studies</span>) assembles a body of expertise to adopt a translational research strategy for the rare autosomal recessive neurological disease, <span style="font-style: italic;">Friedreich’s ataxia</span> (FRDA). <br><br>FRDA is a severely debilitating disease that leads to loss of the ability to walk and dependency for all activities. Some patients have cardiomyopathy that can cause premature death, visual and auditory loss, kyphoscoliosis, pes cavus, diabetes. <br>Onset is usually in childhood, but it may vary from infancy to adulthood. FRDA involves child health and ageing aspects. FRDA affected individuals and clinical specialists are dispersed. This is a hindrance for patients to receive the care they need, and for clinicians and researchers to make progress. <br><br>EFACTS has been created to move past this limitation. EFACTS strongly believes that, 12 years after European researchers discovered the FRDA gene, frataxin, when new treatments for FRDA are being developed, the time is ripe to invest in FRDA research in a concerted Europe-wide fashion. <br>EFACTS gathers the critical mass of researchers and clinicians to exploit the patient base, research reagents and knowledge for progress. This comes when IT can act as a crucial support for collaborative work in collecting patient data and material, making it available to leading researchers for advanced analysis, research and drug development. <br><br>This project proposal has the following scientific and technological objectives: <br><ul><li>Comprehensively populate a European FRDA database, linked to a bio bank; </li><li>Define a panel of clinical assessment tools; </li><li>Build on the knowledge base of frataxin structure and function; </li><li>Build on the knowledge base of the pathogenic cascade; </li><li>Build on the knowledge base of epigenetic mechanisms of frataxin silencing; </li><li>Develop new cellular and animal models for the study of FRDA; </li><li>Identify FRDA biomarkers; </li><li>Identify genetic modifiers of FRDA; </li><li>Develop therapeutics for FRDA.
</li></ul></P><P CLASS="ss_par_tit" STYLE="margin-top: 3.5ex;">Please note</P><P CLASS="ss_par" STYLE="margin-bottom: 1ex; margin-top: 2ex;">The 4th annual patient newsletter is available now and can be downloaded <a href="/html/studies/home/newsletter?asgsid=937c19af8a660d335338ef84ffdb650c">here</a></P></TD></TR></TABLE>
<DIV STYLE="margin-top: 3px;"/></td>
 </tr>
 </tbody></table>
 </td>
 </tr>
 </tbody>
</table>

</td>
</tr>
<tr>
<td class="disclaimer"><div class="rootDisclaimer"><DIV CLASS="impr_hmenu"><SPAN CLASS="impr_hmenu_uns"><A HREF="/html/imprint?asgsid=937c19af8a660d335338ef84ffdb650c">Imprint</A></SPAN>&nbsp;&nbsp;|&nbsp;&nbsp;<SPAN CLASS="impr_hmenu_uns"><A HREF="/html/privacy?asgsid=937c19af8a660d335338ef84ffdb650c">Privacy Statement</A></SPAN>&nbsp;&nbsp;|&nbsp;&nbsp;<SPAN CLASS="impr_hmenu_uns"><A HREF="/html/termsofuse?asgsid=937c19af8a660d335338ef84ffdb650c">Terms of Use</A></SPAN>&nbsp;&nbsp;|&nbsp;&nbsp;<SPAN CLASS="impr_hmenu_uns"><A HREF="/html/liability?asgsid=937c19af8a660d335338ef84ffdb650c">Liability Disclaimer</A></SPAN></DIV></div></td>
</tr>
</table></BODY>
</HTML>
